• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Simulations Plus Inc (NQ: SLP )

    31.83 -0.10 (-0.31%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Simulations Plus Inc

    < Previous 1 2 3 4 5 Next >
    Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Participate in the Stephens Annual Investment Conference
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Releases DILIsym® X
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Releases ADMET Predictor® Version 12
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Stock Drops 15% Despite EPS Beat
    Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date
    From Simulations Plus, Inc.
    Via Business Wire
    QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus
    From QHP Capital
    Via Business Wire
    Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Inc. (NASDAQ: SLP) Near the Top of Equities by Percentage Gain on 4/4
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    U.S. FDA Renews DILIsym® Software Licenses for 7th Year
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus and the University of Bath Awarded New FDA Grant
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Extends Collaboration with Major Toxicology Research Agency
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Launches Corporate Development Initiative
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus to Participate in Upcoming Healthcare Conferences
    From Simulations Plus, Inc.
    Via Business Wire
    Simulations Plus Releases GastroPlus® Version 9.9
    From Simulations Plus, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.